MAPK8IP3 and Alzheimer disease: Knocking out JIP3 in heterozygous AD mouse models worsened amyloid plaque pathology, suggesting that lower JIP3 expression escalates the levels of soluble amyloid peptides, leading to larger plaques and increased axonal dystrophy.